Lot-consistency Clinical Trial of Sabin Strain Inactivated Polio Vaccine

PHASE3CompletedINTERVENTIONAL
Enrollment

1,300

Participants

Timeline

Start Date

May 11, 2020

Primary Completion Date

May 11, 2020

Study Completion Date

October 20, 2020

Conditions
Poliomyelitis
Interventions
BIOLOGICAL

Three doses of experimental sIPV of lot 1 at the schedule of 2,3,4 months of age

Three doses of experimental sIPV of lot 1 at the schedule of 2,3,4 months of age

BIOLOGICAL

Three doses of experimental sIPV of lot 2 at the schedule of 2,3,4 months of age

Three doses of experimental sIPV of lot 2 at the schedule of 2,3,4 months of age

BIOLOGICAL

Three doses of experimental sIPV of lot 3 at the schedule of 2,3,4 months of age

Three doses of experimental sIPV of lot 3 at the schedule of 2,3,4 months of age

BIOLOGICAL

Three doses control wIPV at the schedule of 2,3,4 months of age

Three doses control wIPV at the schedule of 2,3,4 months of age

Trial Locations (4)

652399

Mile City Center for Disease Control and Prevention, Yisa

661000

Gejiu County Center for Disease Control and Prevention, Yisa

663100

Yanshan County Center for Disease Control and Prevention, Wenshan

663200

Qiubei County Center for Disease Control and Prevention, Wenshan

All Listed Sponsors
lead

Sinovac Biotech Co., Ltd

INDUSTRY

NCT04386707 - Lot-consistency Clinical Trial of Sabin Strain Inactivated Polio Vaccine | Biotech Hunter | Biotech Hunter